Voyager Therapeutics Inc (VYGR)
R&D Expenses
$22.04M
Quarterly · Period ending: · USD
VYGR R&D Expenses
Latest reported$22.04Mperiod ending
Latest reported$22.04Mperiod ending
VYGR Quarterly R&D Expenses ($1.43M → $22.04M)
Quarterly R&D Expenses
High-resolution chart · PNG
VYGR r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,041,000 | |
| 24,602,000 | |
| 35,952,000 | |
| 35,866,000 | |
| 31,330,000 | |
| 31,526,000 | |
| 35,583,000 | |
| 30,241,000 | |
| 34,452,000 | |
| 25,896,000 | |
| 24,421,000 | |
| 25,863,000 | |
| 21,985,000 | |
| 18,568,000 | |
| 14,551,000 | |
| 19,337,000 | |
| 12,527,000 | |
| 14,349,000 | |
| 14,020,000 | |
| 17,914,000 | |
| 19,505,000 | |
| 22,346,000 | |
| 21,996,000 | |
| 25,039,000 | |
| 29,423,000 | |
| 32,293,999 | |
| 36,551,000 | |
| 29,777,000 | |
| 28,576,000 | |
| 24,831,000 | |
| 16,914,000 | |
| 16,632,000 | |
| 16,507,000 | |
| 14,853,000 | |
| 13,327,000 | |
| 19,561,000 | |
| 15,300,000 | |
| 14,072,000 | |
| 12,723,000 | |
| 10,309,000 | |
| 10,484,000 | |
| 8,732,000 | |
| 9,220,000 | |
| 6,481,000 | |
| 6,455,000 | |
| 5,523,000 | |
| 2,960,000 | |
| 2,399,000 | |
| 2,107,000 | |
| 1,432,000 |